Letter: Breaking new ground-Understanding the role of ATI-free diet in managing MASLD
- PMID: 38860611
- DOI: 10.1111/apt.18064
Letter: Breaking new ground-Understanding the role of ATI-free diet in managing MASLD
Comment in
-
Letter: Breaking new ground-Understanding the role of ATI-free diet in managing MASLD-Authors' reply.Aliment Pharmacol Ther. 2024 Jul;60(2):304-305. doi: 10.1111/apt.18119. Epub 2024 Jun 11. Aliment Pharmacol Ther. 2024. PMID: 38860612 No abstract available.
References
REFERENCES
-
- Armandi A, Bespaljko H, Mang A, Huber Y, Michel M, Labenz C, et al. Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated Steatotic liver disease: a randomised, controlled proof‐of‐concept study. Aliment Pharmacol Ther. 2024;59:1212–1222. https://doi.org/10.1111/apt.17941
-
- Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877–1887. https://doi.org/10.1002/hep.22848
-
- Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll‐like receptor 4. J Exp Med. 2012;209:2395–2408. https://doi.org/10.1084/jem.20102660
-
- Vici G, Belli L, Biondi M, Polzonetti V. Gluten free diet and nutrient deficiencies: a review. Clin Nutr. 2016;35(6):1236–1241. https://doi.org/10.1016/j.Clnu.2016.05.002
-
- Tortora R, Capone P, De Stefano G, Imperatore N, Gerbino N, Donetto S, et al. Metabolic syndrome in patients with coeliac disease on a gluten‐free diet. Aliment Pharmacol Ther. 2015;41:352–359. https://doi.org/10.1111/apt.13062
Publication types
LinkOut - more resources
Full Text Sources